Investors

Investors Introduction

Monica Healthcare is an independent early-stage medical device company backed by its Founders, Venture Capital , the University of Nottingham and Business Angels from the UK. Since 2006, approx £7M has been raised in Seed and Series A investment rounds. The last investment round of £2M closed in January 2015.

The principal Venture Capital investors in addition to the University of Nottingham are: Catapult Ventures; New Hill; the Lachesis Fund managed by Braveheart Ventures, a group of East Midlands Business Angels (EMBA) and Angel investors associtaed with Wren Capital and London Buisness Angels.

If you are an investor and would like to learn more about Monica Healthcare and the commercial potential for its breakthrough Fetal & Maternal Heart Monitoring products, contact us now.

BOARD - Directors

K D'Silva ( Chairman ); Dr C Barratt (CEO); Dr J F PiĆ©ri(CTO); Prof B Hayes-Gill(CRO); J Nimmo (NED, New Hill); B Venning (NED, University of Nottingham); W Distler (NED)

BOARD - Observers

N Wright ( Catapult); V Hallam ( Braveheart); T Yardley (EMBA); Time de Vere Green (Origin and Wren)

Remuneration Committee

K D'Silva; B Venning; J Nimmo/N Wright

Audit Committee

K D'Silva; B Venning; C Barratt

Investors

Catapult Ventures

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.

Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of pounds in revenue.

The administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

What we do

We have a passion for business and enjoy supporting ambitious entrepreneurs and management teams who share this enthusiasm.

Catapult Ventures is all about value creation through long term relationships - both with our portfolio companies and those who have invested in the funds managed.

Each member of the executive team has some direct portfolio responsibility, meaning they are active board members who play a key role in investee company strategy, hiring of senior personal and sometimes even the finding and meeting of customers. Our executives are also heavily involved in financial strategy which can include leveraging banking relationships and the introduction of new investors for additional funding rounds.

At Catapult Ventures, portfolio responsibility is assigned to the executive that can add the most value. The executive at Monica is Nick Wright who attends regular board meetings.

Funds under Management

Catapult Ventures is an independent Fund Manager. Its owners operate a number of discrete venture capital funds on behalf of a range of public and private sector investors, with a total of c. £100m under the owners management.

Contact details for Catapult: www.catapult-ventures.com

e: mail@catapult-ventures.com
tel: 0116 238 8200

New Hill

Founded in 2001, New Hill Management has two lines of business: fund management and corporate finance services. New Hill Management provides highly focused investment management services for clients seeking high absolute returns from alternative investments, and results-driven corporate finance services to growing companies.

The team is distinguished by the depth and breadth of its partners' experience, and their history of working together since 2001

New Hill invests in unlisted growth companies commercializing technological innovations and scientific advances, primarily in the UK. We are active in the growing private equity secondary market, purchasing portfolios of positions as well as making direct secondary investments in specific companies. We also make primary investments in select companies.

New Hill provides corporate finance services as an advisor and arranger to companies in which New Hill has an ownership stake, as well as in companies in which we do not currently hold an ownership stake.

James Nimmo is a director at Monica

23 Berkeley Square
London W1J 6HE
Phone +44 (0)20 3372 8601
contact@newhillmgt.com

225 Franklin Street
Boston, MA 02110
Phone +1 617 217 2770
contact@newhillmgt.com

University of Nottingham

The University is a leading University in the U.K and a member of the Russell Group of the leading research based universities. The Technology Transfer Group within the University initially manages the spin out of businesses founded on the research at the University. It then continues to support the businesses and continues to invest in them.

Ranked 7th overall in the most recent UK Research Assessment Exercise, which measures the quality of research in Higher Education across the UK, Nottingham is in the UK's Top 10 and the Worlds Top 75 unversities by the Shanghai Jiao Tong and the QS World Rankings. The Univeristy has an impressive pedigree in successful innovation and this includes the invention of MRI by 2003 Nobel Laureate Professor Mansfield.

The University's vision is to be recognized globally by signature contributions especially in global food security, energy and sustainability and health.

Bruce Venning is a director at Monica

Dr Bruce Venning
Commercial Manager
Technology Transfer
Business Engagement and Innovation Services
University of Nottingham
The Sir Colin Campbell Building
Triumph Road
Nottingham
NG7 2TU

Tel: +44 (0)115 846 7891
Fax: +44 (0)115 82 32181

Email: bruce.venning@nottingham.ac.uk
www.nottingham.ac.uk

East Midlands Business Angels Ltd

East Midlands Business Angels Ltd raises investment capital for growing companies. We have been investing since 1997. Investments completed range from £20,000 to over £1 million. Our investors back talented, committed managers running businesses with the potential for strong growth.

Tom Yardley attends regular board meetings at Monica.

Tom Yardley
East Midlands Business Angels Ltd
PO Box 333
Newark
NG23 6FQ

Telephone: 01636 708717
Mobile: 07767 443843

Email: tom.yardley@em-ba.co.uk
www.em-ba.co.uk

Origin Capital

Origin Capital is an investor in early-stage technology businesses across a wide range of individual sub-sectors, including high-value manufacturing, life sciences, software and IT infrastructure, but we also have interests and experience in other fields, including financial services, consumer products and media. The investment transactions we participate in are typically £50k – £2m in round size, with pre-money valuations of £200k – £10m.
Origin is led by Tim de Vere Green, CEO and comprises individuals with backgrounds in business consultancy, accountancy, finance and venture capital. Each of us has hands-on experience in early-stage enterprises in the sectors where we work.
For more information, please visit www.origingroup.co.uk or read about our latest news.

Wren Capital

Wren Capital, whose managing partner is Rajat Malhotra (UK Business Angels Associations Angel Investor of the Year for 2013) specialises in early stage investing across a variety of sectors. Our portfolio currently includes companies in the life sciences, B2B software, semiconductor, energy, and high-tech engineering sectors. Our involvement is tailored to the needs of each business and we aim to be a supportive value-adding investor. We generally follow a co-investment model and have links with a number of universities, VC firms, business schools, angel networks and a trusted network of high quality investors who share our investment philosophy.
For more information please see:  www.wrencapital.co.uk or contact:
Rajat Malhotra
contact@wrencapital.co.uk
020 3397 3390

The Lachesis Fund

The Lachesis Fund invests in spin out companies emerging from our partner Universities (De Montfort University, University of Derby, Loughborough University, University of Leicester, University of Lincoln, University of Northampton, University of Nottingham and Nottingham Trent University). Investments range in size from £25K to £250K.

Lachesis is a £10M fund, seeking to fill the 'seed-corn' funding gap that exists for very early technologies in the higher education sector and is part-financed by the European Regional Development Fund.

Investments from the fund will help the commercialisation of promising University research by starting a new business, levering in co-investment and furthering the enterprise culture within the partner institutions.

Investments support projects in various ways: securing of commercial staff, enhancing and verifying intellectual property, prototype development, market research and business plan preparation.

The Lachesis fund invests in projects where it sees the potential for financial return. It is not a grant funder.

The Fund is managed by Braveheart Ventures and Viv Hallam attends regular board meetings.

www.lachesisfund.co.uk

ISO13485